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Abstract. Milk vending machines (MVMs) are growing in popularity in Kenya and worldwide. Milk vending machines
dispense varying quantities of locally sourced, pasteurized milk. The Kenya Dairy Board has a regulatory framework, but
surveillance is weak because of several factors. Milk vending machines’ milk is not routinely screened for antibiotics,
thereby increasing potential for antibiotic misuse. To investigate, a total of 80 milk samples from four commercial
providers (N = 25), street vendors (N = 21), and three MVMs (N = 34) were collected and screened in Eldoret, Kenya.
Antibiotic residue surveillance occurred during December 2016 and January 2017 using Idexx SNAPAU2 tests for tetracy-
clines, sulfamethazine, beta-lactams, and gentamicin. Overall, 24% of MVM samples and 24% of street vendor samples
were presumably positive for at least one antibiotic. No commercial samples were positive. Research into cost-effective
screening methods and increased monitoring by food safety agencies are needed to uphold HAACPAU3 for improving
antibiotic stewardship throughout the Kenyan private dairy industry.
Beyond the spread of antimicrobial resistance in the hos-
pital environment, enhanced understanding of veterinary and
environmental health factors (e.g., antibiotic stewardship in
agriculture, improved sanitation and hygiene, etc.) are needed
to slow or reverse the rapid and global spread of antibiotic-
resistant bacteria.1 The greatest concerns for antibiotic re-
sistance (AR) development are arising in low- andmiddle-income
nations,wherescience is lacking importantquantitativedata from
these high-risk areas for AR development.1 Globally, research
needs of AR are great in Africa, particularly because of limited
resources for discouraging antibiotic misuse in clinic, home, and
farm settings.2–5 Antibiotic resistance is a problem without bor-
ders as AR genes can be transmitted rapidly from animal-
associated flora (e.g., manure bacteria) to nonpathogenic or
pathogenic flora in the environment. Such AR bacteria may then
beacquiredandshedby livestock,wildlife,orhumansthat travel.6
In East Africa, the role of cattle and cattle antibiotics for pro-
moting human-acquired AR has gained great attention among
medical, veterinary, and global public health communities.6,7 In
rural and peri-urban areas of Kenya, humans and livestock are in
close proximity daily and may share drinking water sources.
Animal-relatedfecalcontaminationofwater,soil,andfoodsupplies
with AR flora may be possible in the presence of antibiotics.7
Among these and several other reasons, a recent U.K. report
warned that if unchecked, antimicrobial usage will result in AR
infections being theworld’s leading killer by the year 2050with the
mostsignificantAR-relatedmortalityanticipatedtooccur inAfrica.8
Because locally sourced milk is routinely produced and
consumed in Kenya, milk has been a focus of research in-
vestigations since theearly 2000swhenantibiotic usebecame
widespread and increased in the dairy industry for boosting
agricultural productivity.9 Such investigations produced an
increased regulation of antibiotics among large facilities pro-
ducing wholesale milk for regional markets in East Africa. In
2006, the East African Standard (EAS) for pasteurized milk10
was established, thereby requiring regional milk sellers to
comply with the maximum residue limits (MRLs) for veterinary
drugs from the Codex Alimentarius.11Smaller producers remain
a cause for concern as evidenced in the frequency of multidrug-
resistant Staphylococcus aureus, which are observed in small
farm milk samples at a rate double that of Kenya’s large farm
rate.12 The issue has become of greater concern with the de-
velopment of milk vending machines (MVMs). Milk vending
machines are not automated teller machines (ATMs); however,
locally, they are referred to as “Milk ATMs.” Milk vending ma-
chines are gaining popularity in low- andmiddle-income nations
worldwide. In Kenya, MVMs are often advertised as providing
locally sourced milk from small farmers. Many supermarkets in
Kenya have an MVM at the storefront where consumers may
purchase milk in various quantities dispensed in volumes as
small as0.25L.Government regulators inKenyaarenotcurrently
examining milk from these MVMs for antibiotic residues. The
Ministry of Agriculture, Livestock, and Fisheries is striving to
address deficiencies in the national dairy program for local sell-
ers.13 Commercial providers adhere to the EAS10 as they may
export product throughout East Africa.
The widespread growth of MVMs in Uasin Gishu County
warranted the study. In January 2016, in a meeting with
county officials pertaining to rural household water quality,
county officials independently raised concerns regarding
MVMs and the potential for antibiotic residues. We therefore
hypothesized that the prevalence of detectable antibiotic
residues in MVM milk would be higher than in commercially
packaged milk from the same supermarkets housing the
MVMs. Given a recent Kenyan study demonstrated 44% of
milk samples from smallholder collections in adjacent coun-
ties contained beta-lactam antibiotic residues,14we expected
to find positive detections in MVM samples.
For screening for elevated levels of antibiotic residues in
milk fromMVMs, sampleswere collected in sterile Nasco (Fort
Atkison, WI) Whirl-Pak containers from Eldoret, located in
western Kenya (Uasin Gishu County). Samples were also
collected in Whirl-Paks from street vendors. Prepackaged
commercial sampleswere collected from four different brands
at the supermarket. The samples were collected at least
2 days apart from each location during the months of De-
cember 2016 and January 2017. All sampleswere transported
in a cooler and testing occurred within 4 hours of collection.
IDEXX (Westbrook, ME) SNAP® tests were used in accor-
dance with the manufacturer’s instruction for screening for
elevated levels of beta-lactams, sulfamethazine, tetracyclines,
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andgentamicin. EachSNAP test device isdesignedasasingle-
use, field-portable enzyme-linked immunosorbant assay,
which allowed for ease of use in the region.15 The residue de-
tection thresholds of the SNAP tests relate to the manufac-
turer’sdesign for compliancemonitoring thatmeets or exceeds
the U.S. Food and Drug Administration’s (FDA) protocols for
evaluating FDA established tolerance, safe, and/or action lev-
els. Sample resultswere recorded as positive or negative using
the color indicator unique for each test. Although presumably
positive by the SNAP test,T1 Table 1 demonstrates the potential
for some positive samples to exceed the U.S. criteria while
being below MRLs defined in the Codex Alimentarius as an
international food standard. For drawing greater conclusions
among presumably positive samples, an analytical analysis
would be required to obtain true concentrations.
Overall, 80 samples were collected with most coming from
three MVMs (N = 34) (T2 Table 2. For MVMs and street vendors,
positive results were periodically observed. However, no
prepackaged commercial milk samples tested positive for any
of the antibiotic residues evaluated (Table 2). In regard to
MVMs, 24% of samples had a positive result for at least one
antibiotic. Similarly, 24% of samples from unique street ven-
dors tested positive for at least one antibiotic (Table 2). No
sample tested positive for more than one antibiotic.
Fisher’s exact tests were used to determine if significant
differences existed between the frequencies of any antibiotic
detection inmilk fromtheMVMs(8/34), commerciallypackaged
milk (0/25), and street vendor milk (5/21). In comparing antibi-
otic residue prevalence in MVMs versus commercially pack-
aged milk, there was a significant difference (P = 0.016).
Similarly, there was a significant difference in antibiotic residue
prevalence between street vendor milk samples and the com-
mercially packagedmilk (P = 0.015). There was no difference in
the frequency of milk samples that tested positive for any an-
tibiotic between MVM and street vendor samples (P = 0.614).
Among MVMs, there was a difference in the prevalence of
MVMswith a positive antibiotic detection. Specifically, 45%of
MVM samples (5 of 11) from MVM-1 were positive for at least
one antibiotic residue ( T3Table 3), which was significantly higher
than the zero of 12 from MVM-2 (P = 0.014). Among positive
MVM and street vendor samples, tetracycline and gentamicin
were most prevalent. For MVM-1, three separate antibiotics
were found across 11 samples over 24 sample days. Table 3
illustrates that one MVM (MVM-1) may contain multiple resi-
dues during a relatively short period.
The results presented here are limited, as positive results
werenot furtherevaluatedwithanalytical chemistry techniques.
In addition, with regard to tetracycline, the screening method
sensitivity used here was at 50 ppb rather than 100 ppb
(Table1), andpositivedetectionsof tetracyclines inKenyanmilk
by screening are not always substantiated after analytical lab-
oratory evaluation.16 It is noteworthy that no commercial
samples tested positive using the SNAP screening methods.
Overall, observing antibiotic residues in milk is not un-
expected in Kenya or abroad.9,17,18 Noteworthy here is the
emerging, rapidly expanding, understudied MVM concept in
Kenya and abroad. For the growing MVM supply chain, our
results indicate a greater need for further investigating Kenyan
MVMs and antibiotic usage in local milk supply chains. Re-
cently (2017), in nearby Nakuru County, 28.8% (23/80) of milk
samples from peri-urban areas were positive for antibiotic
residues.16Among our noncommercial samples (MVM+ street
vendor) in Eldoret, we observed 23.6% (13/55) positive.
As invasive antibiotic-resistant Salmonella disease rises at
alarming rates in sub-SaharanandEastAfrica,19alongwithAR
in other pathogens of clinical relevance,20 enhanced efforts to
mitigate and prevent AR in the environment are needed. Pri-
ority actions are needed for upholding EAS pasteurized milk
specifications, which include the Codex Alimentarius MRLs,
for local milk. Such priorities have been identified in the Na-
tional Dairy Development Policy including procuring reliable
testing equipment, providing testing training, sensitizing stake-
holders on the importance of appropriate antibiotic use, and
enforcement of standards.13
In Kenya, current food safety regulations remain frag-
mented over four agencies. Coordination and surveillance
remain challenging. Milk seller’s income also limits stake-
holder engagement. Research into cost-effective screening
methods and incentivizing MVM owner education may help.
Kenyan regulators may benefit from developing a general
decision tree for evaluating antibiotic residues, which would
identify different options for hazard identification, hazard
characterization, and exposure assessment.
The present study is limited. Analytical techniques were not
used to confirm if residue concentrations exceeded MRLs. In
addition, MVMs were replenished multiple times daily be-
cause of their popularity, but common suppliers of the units or
TABLE 1
Comparison of residue detection thresholds for SNAP tests used in
this study vs. the MRLs for each antibiotic as presented in the July
2017 Codex Alimentarius11
SNAP test Agent
Detection level
(ppb)
Codex MRLs
(ppb)
NBLAU7 beta-lactams Amoxicillin £ 8 4
Ampicillin £ 6
Ceftioufur £ 20 100
Cephapirin £ 12
Penicillin £ 4 4
Sulfamethazine Sulfamethazine £ 10 25
Tetracycline Tetracycline £ 50 100*
Chlortetracycline £ 100 100*
Oxytetracycline £ 50 100*
Gentamicin Gentamicin £ 30 200
MRLs = maximum residue levels.
* Combined totals of all three in the tetracycline group should not exceed 100 ppb.
TABLE 2
Prevalence of detectable levels of antibiotic residues in milk for the various sample types from Eldoret, Kenya
Sample type
Tetracyclines Sulfamethazine Beta-lactams Gentamicin Any antibiotic
± (%) ± (%) ± (%) ± (%) ± (%)
Commercial 0/25 (0) 0/25 (0) 0/25 (0) 0/25 (0) 0/25 (0)
Milk MVM 2/34 (5.9) 1/34 (2.9) 2/34 (5.9) 3/34 (8.8) 8/34 (24)
Street vendor 3/21 (14) 0/21 (0) 0/21 (0) 2/21 (9.5) 5/21 (24)
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incomplete removal of milk could contaminate bulk samples
with detectable levels of antibiotic residue. Additional re-
search and surveillance pertaining to MVMs is recommended
for identifying the sources of antibiotic entry into the supply
chain. Overall, given MVMs are growing in popularity, further
investigations and surveillance are strongly encouraged.
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